Close this search box.

According to the CDC, many seniors are now entitled to additional COVID booster shots

COVID booster shots

On Wednesday, the Centers for Disease Control and Prevention approved a wide range of changes that had previously been approved by the Food and Drug Administration. As a result, many senior citizens are now able to receive a second dose of the COVID-19 vaccine.

Initiative regarding Covid Booster

The CDC’s move clears the last obstacle for qualified Americans to have the option to get one more round of the sponsor shots that were carried out last year from Moderna and Pfizer-BioNTech, which had been refreshed to incorporate a “bivalent” recipe for the BA.4 and BA.5 variations of Omicron.

After receiving their last bivalent shot, people with compromised immune systems can receive additional doses as early as two months later. The Biden administration has made sweeping changes to streamline Moderna and Pfizer-BioNTech’s numerous immunization schedules, bringing them closer to the annual seasonal flu shot. The new round of shots is one of those changes.

Dr. Peter Marks, the FDA’s top vaccines official, stated in a release announcing their authorization on Tuesday. “At today’s stage of epdemic, data support simplifying the use of the authorized mRNA bivalent COVID-19 vaccines and the agency believes that this approach will help encourage future vaccination.”

The CDC reports that approximately 20% of adults and 43% of seniors have received their first dose of the bivalent vaccine thus far. In some other nations, additional shots have already been cleared. This month, the United Kingdom began providing second doses of the bivalent vaccine to some of its most at-risk residents, such as those over the age of 75.

Americans who haven’t been vaccinated yet will now be able to start with shots of the bivalent vaccine rather than the two initial “monovalent” shots that were meant to protect against the original strain of the virus under the plan that was first supported by a panel of outside vaccine advisers from the Food and Drug Administration (FDA) in January.

The previous monovalent COVID vaccines, which are no longer being produced and are coming to an end, are no longer available, so the Biden administration has been working to phase them out.

Read More news: Click here



Copyright 2023 © Insightscare Magazine ( a Digital Ink brand ) All rights reserved.